Literature DB >> 9249836

Evaluation of the safety and efficacy of deep sedation for electrophysiology procedures administered in the absence of an anesthetist.

M J Geiger1, A Wase, M M Kearney, M J Brandon, V Kent, K H Newby, A Natale.   

Abstract

UNLABELLED: Several procedures performed in the electrophysiology laboratory (EP lab) require surgical manipulation and are lengthy. Patients undergoing such procedures usually receive general anesthesia or deep sedation administered by an anesthesiologist. In 536 consecutive procedures performed in the EP lab, we assessed the safety and efficacy of deep sedation administered under the direction of an electrophysiologist and in the absence of an anesthetist. Patients were monitored with pulse oximetry, noninvasive blood pressure recordings, and continuous ECGs. The level of consciousness and vital signs were evaluated at 5-minute intervals. Deep sedation was induced in 260 patients using midazolam, phenergan, and meperidine, then maintained with intermittent dosing of meperidine at the following mean doses: midazolam 0.031 +/- 0.024 mg/kg; phenergan 0.314 +/- 0.179 mg/kg; and meperidine 0.391 +/- 0.167 mg/kg per hour. In the remaining 276 patients, deep sedation was induced with midazolam and fentanyl and maintained with a continuous infusion of fentanyl at a mean dose of 2.054 +/- 1.43 micrograms/kg per hour. Fourteen patients experienced a transient reduction in oxygen saturation that was readily reversed following administration of naloxone. An additional 11 patients desaturated secondary to partial airway obstruction, which resolved after repositioning the head and neck. Fourteen patients experienced hypotension with fentanyl. All but one returned to baseline blood pressures following an infusion of normal saline. No patient required intubation and no death occurred. Only three patients had recollection of periprocedure events. No patient remembered experiencing pain with the procedure. Hospital stays were not prolonged as a result of the sedation used. IN
CONCLUSION: (1) deep sedation during EP procedures can be administered safely under the guidance of the electrophysiologist without an anesthetist present; (2) the drugs used should be readily reversible in case of respiratory depression; and (3) this approach may reduce the overall cost of the procedures in the EP lab, maintaining adequate patient comfort.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9249836     DOI: 10.1111/j.1540-8159.1997.tb03571.x

Source DB:  PubMed          Journal:  Pacing Clin Electrophysiol        ISSN: 0147-8389            Impact factor:   1.976


  6 in total

1.  Heart transplantation in children with mitochondrial cardiomyopathy.

Authors:  D Bonnet; P Rustin; A Rötig; J Le Bidois; A Munnich; P Vouhé; J Kachaner; D Sidi
Journal:  Heart       Date:  2001-11       Impact factor: 5.994

2.  Sedation by physician with diazepam for DC cardioversion of atrial arrhythmias.

Authors:  P J Pugh; P Spurrell; K Kamalvand; A N Sulke
Journal:  Heart       Date:  2001-11       Impact factor: 5.994

3.  Role of conscious sedation for external cardioversion.

Authors:  R Raipancholia; L Sentinella; M Lynch
Journal:  Heart       Date:  2001-11       Impact factor: 5.994

4.  Effect of circadian rhythm on response to carotid sinus massage.

Authors:  Y Atmaca; A Alpman; M Kilickap; S Murat; D Oral
Journal:  Heart       Date:  2001-11       Impact factor: 5.994

5.  Intravenous sedation for cardiac procedures can be administered safely and cost-effectively by non-anesthesia personnel.

Authors:  Anna Kezerashvili; John D Fisher; Jessica DeLaney; Savi Mushiyev; Eileen Monahan; Vanessa Taylor; Soo G Kim; Kevin J Ferrick; Jay N Gross; Eugen C Palma; Andrew K Krumerman
Journal:  J Interv Card Electrophysiol       Date:  2008-02-14       Impact factor: 1.900

Review 6.  Sedation in the Electrophysiology Laboratory: A Multidisciplinary Review.

Authors:  Neal S Gerstein; Andrew Young; Peter M Schulman; Eric C Stecker; Peter M Jessel
Journal:  J Am Heart Assoc       Date:  2016-06-13       Impact factor: 5.501

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.